As elimination of cancer cell by irreversible cell death is a desirable outcome of any effective cancer treatment (93,94), we examined whether the targeting of CDK12 or P-TEFb switches the fate of CDK7-inhibited cells from cell-cycle arrest to apoptosis. Here, CDK12 is linked to cancer.